glenmark pharmaceuticals
Jump to
199 Results Found
  • Glenmark Pharmaceuticals gets USFDA nod for generic version of acne treatment gel Mar 15, 2019 03:52 PM IST

    Glenmark Pharmaceuticals gets USFDA nod for generic version of acne treatment gel

    Glenmark's current portfolio consists of 151 products authorised for distribution in the US.

  • Glenmark Pharma appoints Alessandro Riva as CEO of its new innovation company in US Mar 06, 2019 10:37 AM IST

    Glenmark Pharma appoints Alessandro Riva as CEO of its new innovation company in US

    "Alessandro is currently Executive Vice President, Oncology Therapeutics and Cell Therapy for Gilead Sciences. The appointment is effective April 2, 2019," Glenmark Pharma said in a regulatory filing.

  • Glenmark Pharma gets USFDA nod for hypertension drug Mar 05, 2019 10:59 AM IST

    Glenmark Pharma gets USFDA nod for hypertension drug

    The approved products is a generic version of Boehringer Ingelheim Pharmaceuticals Inc's Micardis HCT tablets.

  • Glenmark gets USFDA nod for generic skin inflammation treatment foam Feb 18, 2019 12:59 PM IST

    Glenmark gets USFDA nod for generic skin inflammation treatment foam

    The approval has been granted by the USFDA to Glenmark Pharmaceuticals, US, for clobetasol propionate foam, 0.05 percent, a generic version of Olux Foam, 0.05 percent, of Mylan Pharmaceuticals, the company said in a statement.

  • Glenmark Pharma gets USFDA nod for drug for patients on dialysis Feb 11, 2019 12:32 PM IST

    Glenmark Pharma gets USFDA nod for drug for patients on dialysis

    "Glenmark Pharmaceuticals Inc, USA (Glenmark) has been granted final approval by the United States Food and Drug Administration (USFDA) for Sevelamer Hydrochloride tablets in the strengths of 400 mg and 800 mg," the company said in a BSE filing.

  • Glenmark inks pact with South Korea's Yuhan Corp to commercialise Ryaltris Jan 10, 2019 02:12 PM IST

    Glenmark inks pact with South Korea's Yuhan Corp to commercialise Ryaltris

    Ryaltris is indicated for treatment of symptoms associated with seasonal allergic rhinitis (SAR) in patients over 12 years of age

  • Glenmark Pharma eyes up to 15% consolidated revenue growth over 3 to 5 years Jan 08, 2019 04:52 PM IST

    Glenmark Pharma eyes up to 15% consolidated revenue growth over 3 to 5 years

    Glenmark is targeting a consolidated revenue growth of 12-15 percent over the next 3-5 years, while focusing on margin expansion, the company said.

  • Glenmark gets USFDA approval for ear drops Dec 18, 2018 11:08 AM IST

    Glenmark gets USFDA approval for ear drops

    Glenmark Pharmaceuticals Inc, USA has been granted final approval by the USFDA for Fluocinolone Acetonide Oil, 0.01 per cent (ear drops), a generic version of DermOtic Oil.

  • Glenmark gets USFDA nod for skin ointment Dec 17, 2018 11:38 AM IST

    Glenmark gets USFDA nod for skin ointment

    Glenmark said it is eligible for 180 days of competitive generic therapy (CGT) exclusivity upon commercialisation.

  • Glenmark Pharma gets tentative USFDA nod for skin treatment drug Nov 26, 2018 10:58 AM IST

    Glenmark Pharma gets tentative USFDA nod for skin treatment drug

    The approved product is a generic version of Mylan Pharmaceuticals Inc's Olux-E Foam, 0.05 per cent.

  • Glenmark gets USFDA nod for pneumonia treatment drug Nov 22, 2018 11:06 AM IST

    Glenmark gets USFDA nod for pneumonia treatment drug

    The approved drug is a generic version of GlaxoSmithKline's Mepron Oral Suspension of similar strength.

  • Glenmark Pharma gains 2% on USFDA approval for antimicrobial drug Nov 22, 2018 10:04 AM IST

    Glenmark Pharma gains 2% on USFDA approval for antimicrobial drug

    Atovaquone is a generic version of Mepron oral suspension, 750 mg/5 mL, of GlaxoSmithKline LLC.

  • Glenmark gets USFDA nod for generic acne treatment gel Nov 20, 2018 01:12 PM IST

    Glenmark gets USFDA nod for generic acne treatment gel

    The approval granted to Glenmark Pharmaceuticals Inc by by the US Food and Drug Administration (USFDA) is for Azelaic Acid Gel, 15 per cent, which is a generic version of Finacea Gel (15 per cent) of Leo Pharma, the company said in a statement.

  • Glenmark gets USFDA nod for multiple sclerosis medication Nov 16, 2018 10:50 AM IST

    Glenmark gets USFDA nod for multiple sclerosis medication

    Glenmark Pharmaceuticals, USA, has been granted final approval by the United States Food and Drug Administration (USFDA) for Teriflunomide tablets in the strengths of 7 mg and 14 mg, the company said in a BSE filing.

  • Glenmark to launch phase 1 trial in solid tumors for anti-myeloma drug Nov 08, 2018 11:41 AM IST

    Glenmark to launch phase 1 trial in solid tumors for anti-myeloma drug

    "The company intends to file an Investigational New Drug (IND) application for GBR 1342 in solid tumors and initiate a clinical trial in 2019," the company said in a regulatory filing.

  • Glenmark launches hair loss treatment product in Russia Nov 01, 2018 11:22 AM IST

    Glenmark launches hair loss treatment product in Russia

    The product catering to both male and female patients will be exclusively marketed in Russia by Glenmark Impex LLC, a subsidiary of the company, under a licensing agreement with Denmark's Pharma Medico ApS.

  • Glenmark gets USFDA nod for generic Derma-Smoothe Topical Oil Oct 30, 2018 10:56 AM IST

    Glenmark gets USFDA nod for generic Derma-Smoothe Topical Oil

    The company's current portfolio consists of 141 products authorised for distribution at the US marketplace and 58 Abbreviated New Drug Applications (ANDAs) pending approval with the USFDA.

  • Glenmark gets USFDA nod for generic skin inflammation oil Oct 26, 2018 01:27 PM IST

    Glenmark gets USFDA nod for generic skin inflammation oil

    Glenmark Pharmaceuticals Inc has been granted final approval by the United States Food & Drug Administration (USFDA) for the oil in the strength of 0.01 percent, the Mumbai-based company said in a statement.

  • Glenmark Pharma gets USFDA nod for menopause symptom relief drug Sep 17, 2018 11:30 AM IST

    Glenmark Pharma gets USFDA nod for menopause symptom relief drug

    "Glenmark Pharmaceuticals Inc., USA has been granted final approval by the United States Food and Drug Administration (USFDA) for Estradiol Vaginal Inserts USP, 10 mcg," the company said in a regulatory filing Monday.

  • Glenmark inks pact with private equity firm True North Aug 11, 2018 10:35 AM IST

    Glenmark inks pact with private equity firm True North

    The new entity would be named as 'Integrace Private Ltd' and will market the product portfolio in India and Nepal, Glenmark said in a statement.

  • Glenmark Q1 net at Rs 232.99 crore Aug 11, 2018 10:00 AM IST

    Glenmark Q1 net at Rs 232.99 crore

    Total revenue from operations during the period under review was at Rs 2,165.62 crore. It was at Rs 2,363 crore in the same quarter last fiscal.

  • Glenmark to appeal against CCI order before NCLAT Jul 17, 2018 03:05 PM IST

    Glenmark to appeal against CCI order before NCLAT

    Glenmark disagrees with the findings of the Commission. While there is no material impact of the order, the company will file an appeal before the National Company Law Appellate Tribunal (NCLAT), the drug maker said.

  • Glenmark Pharmaceuticals gets USFDA nod for cholesterol lowering drug Jul 17, 2018 11:15 AM IST

    Glenmark Pharmaceuticals gets USFDA nod for cholesterol lowering drug

    Quoting IQVIA sales data for the 12-month period ended May 2018, the company said Welchol achieved annual sales of around $73 million.

  • Glenmark launches Akynzeo in India under licensing pact with Helsinn Jul 12, 2018 02:02 PM IST

    Glenmark launches Akynzeo in India under licensing pact with Helsinn

    The product has been developed by Helsinn, and Glenmark has exclusive marketing rights for it in India and Nepal, the company said in a statement.

  • USFDA approves first product from Glenmark's US plant Jun 19, 2018 04:29 PM IST

    USFDA approves first product from Glenmark's US plant

    The US Food and Drug Administration (USFDA) has provided its first supplemental Abbreviated New Drug Application (ANDA) approval for the company's plant in Monroe, Glenmark said in a statement.

Sections